These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32572869)

  • 21. Detection of SARS-CoV-2 antibodies using commercial assays and seroconversion patterns in hospitalized patients.
    Tuaillon E; Bolloré K; Pisoni A; Debiesse S; Renault C; Marie S; Groc S; Niels C; Pansu N; Dupuy AM; Morquin D; Foulongne V; Bourdin A; Le Moing V; Van de Perre P
    J Infect; 2020 Aug; 81(2):e39-e45. PubMed ID: 32504735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan.
    Chen SY; Lee YL; Lin YC; Lee NY; Liao CH; Hung YP; Lu MC; Wu JL; Tseng WP; Lin CH; Chung MY; Kang CM; Lee YF; Lee TF; Cheng CY; Chen CP; Huang CH; Liu CE; Cheng SH; Ko WC; Hsueh PR; Chen SC
    Emerg Microbes Infect; 2020 Dec; 9(1):2157-2168. PubMed ID: 32940547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parental Coronavirus Disease 2019 Testing of Hospitalized Children: Rethinking Infection Control in a Pandemic.
    Hassoun A; Prasad N; Pugh S; Merced I; Abularrage J; Sharma M
    J Pediatric Infect Dis Soc; 2020 Nov; 9(5):564-565. PubMed ID: 32856705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic surveillance of SARS-CoV-2 shedding and neutralizing antibody in children with COVID-19.
    Liu P; Cai J; Jia R; Xia S; Wang X; Cao L; Zeng M; Xu J
    Emerg Microbes Infect; 2020 Dec; 9(1):1254-1258. PubMed ID: 32515685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip.
    Prazuck T; Colin M; Giachè S; Gubavu C; Seve A; Rzepecki V; Chevereau-Choquet M; Kiani C; Rodot V; Lionnet E; Courtellemont L; Guinard J; Pialoux G; Hocqueloux L
    PLoS One; 2020; 15(9):e0237694. PubMed ID: 32941461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of SARS-CoV-2 specific IgG antibodies in District Srinagar, northern India - A cross-sectional study.
    Khan SMS; Qurieshi MA; Haq I; Majid S; Bhat AA; Nabi S; Ganai NA; Zahoor N; Nisar A; Chowdri IN; Qazi TB; Kousar R; Lone AA; Sabah I; Nabi S; Sumji IA; Kawoosa MF; Ayoub S
    PLoS One; 2020; 15(11):e0239303. PubMed ID: 33175878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing for COVID-19: a few points to remember.
    Krátká Z; Luxová Š; Malíčková K; Fürst T; Šimková H
    Cas Lek Cesk; 2020; 159(2):72-77. PubMed ID: 32434339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay.
    McDade TW; McNally EM; Zelikovich AS; D'Aquila R; Mustanski B; Miller A; Vaught LA; Reiser NL; Bogdanovic E; Fallon KS; Demonbreun AR
    PLoS One; 2020; 15(8):e0237833. PubMed ID: 32797108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Delayed specific IgM antibody responses observed among COVID-19 patients with severe progression.
    Shen L; Wang C; Zhao J; Tang X; Shen Y; Lu M; Ding Z; Huang C; Zhang J; Li S; Lan J; Wong G; Zhu Y
    Emerg Microbes Infect; 2020 Dec; 9(1):1096-1101. PubMed ID: 32476607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody kinetics and serologic profiles of SARS-CoV-2 infection using two serologic assays.
    Kweon OJ; Lim YK; Kim HR; Kim MC; Choi SH; Chung JW; Lee MK
    PLoS One; 2020; 15(10):e0240395. PubMed ID: 33091042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARS-CoV-2 S1 and N-based serological assays reveal rapid seroconversion and induction of specific antibody response in COVID-19 patients.
    Algaissi A; Alfaleh MA; Hala S; Abujamel TS; Alamri SS; Almahboub SA; Alluhaybi KA; Hobani HI; Alsulaiman RM; AlHarbi RH; ElAssouli MA; Alhabbab RY; AlSaieedi AA; Abdulaal WH; Al-Somali AA; Alofi FS; Khogeer AA; Alkayyal AA; Mahmoud AB; Almontashiri NAM; Pain A; Hashem AM
    Sci Rep; 2020 Oct; 10(1):16561. PubMed ID: 33024213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of a commercially available SARS-CoV-2 serological immunoassay.
    Meyer B; Torriani G; Yerly S; Mazza L; Calame A; Arm-Vernez I; Zimmer G; Agoritsas T; Stirnemann J; Spechbach H; Guessous I; Stringhini S; Pugin J; Roux-Lombard P; Fontao L; Siegrist CA; Eckerle I; Vuilleumier N; Kaiser L;
    Clin Microbiol Infect; 2020 Oct; 26(10):1386-1394. PubMed ID: 32603801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid Determination of SARS-CoV-2 antibodies using a bedside, point-of-Care, serological test.
    Dortet L; Emeraud C; Vauloup-Fellous C; Khecharem M; Ronat JB; Fortineau N; Roque-Afonso AM; Naas T
    Emerg Microbes Infect; 2020 Dec; 9(1):2212-2221. PubMed ID: 32969769
    [No Abstract]   [Full Text] [Related]  

  • 34. Four point-of-care lateral flow immunoassays for diagnosis of COVID-19 and for assessing dynamics of antibody responses to SARS-CoV-2.
    Wu JL; Tseng WP; Lin CH; Lee TF; Chung MY; Huang CH; Chen SY; Hsueh PR; Chen SC
    J Infect; 2020 Sep; 81(3):435-442. PubMed ID: 32553841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longer Duration of SARS-CoV-2 Infection in a Case of Mild COVID-19 With Weak Production of the Specific IgM and IgG Antibodies.
    Guo X; Zeng L; Huang Z; He Y; Zhang Z; Zhong Z
    Front Immunol; 2020; 11():1936. PubMed ID: 32849650
    [No Abstract]   [Full Text] [Related]  

  • 36. The explosion of new coronavirus tests that could help to end the pandemic.
    Guglielmi G
    Nature; 2020 Jul; 583(7817):506-509. PubMed ID: 32681157
    [No Abstract]   [Full Text] [Related]  

  • 37. Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays.
    Merrill AE; Jackson JB; Ehlers A; Voss D; Krasowski MD
    J Appl Lab Med; 2020 Nov; 5(6):1351-1357. PubMed ID: 32717056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroprevalence of antibodies against SARS-CoV-2 among health care workers in a large Spanish reference hospital.
    Garcia-Basteiro AL; Moncunill G; Tortajada M; Vidal M; Guinovart C; Jiménez A; Santano R; Sanz S; Méndez S; Llupià A; Aguilar R; Alonso S; Barrios D; Carolis C; Cisteró P; Chóliz E; Cruz A; Fochs S; Jairoce C; Hecht J; Lamoglia M; Martínez MJ; Mitchell RA; Ortega N; Pey N; Puyol L; Ribes M; Rosell N; Sotomayor P; Torres S; Williams S; Barroso S; Vilella A; Muñoz J; Trilla A; Varela P; Mayor A; Dobaño C
    Nat Commun; 2020 Jul; 11(1):3500. PubMed ID: 32641730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of three immunochromatographic tests for rapid detection of antibodies against SARS-CoV-2.
    Guedez-López GV; Alguacil-Guillén M; González-Donapetry P; Bloise I; Tornero-Marin C; González-García J; Mingorance J; García-Rodríguez J;
    Eur J Clin Microbiol Infect Dis; 2020 Dec; 39(12):2289-2297. PubMed ID: 32808111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.